Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding
NCT ID: NCT03017664
Last Updated: 2020-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
28 participants
OBSERVATIONAL
2018-01-15
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Usefulness of Protein-enriched Infant Formula in Pediatric Intensive Care.
NCT03901742
Nutritional Status on Admission to Pediatric Intensive Care
NCT02293434
Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-Based Formula
NCT03048409
Early Versus Late Parenteral Nutrition in the Pediatric Intensive Care Unit
NCT01536275
Continuous Vs Bolus Protein (Protein Regimen Outcomes) in Critically Ill Children (Kids in Distress)
NCT06721923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RFG
Retrospective review of enteral feeding in pediatric ICU patients for up to 5 days
Retrospective review of enteral tube feeding formula
Enteral formula tube feeding will be retrospectively reviewed
PFG
Pediatric ICU population to be fed a peptide-based enteral formula with higher protein and higher calories for up to 5 days
Peptide-based enteral formula
Peptide-based, higher protein and higher calorie enteral formula
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peptide-based enteral formula
Peptide-based, higher protein and higher calorie enteral formula
Retrospective review of enteral tube feeding formula
Enteral formula tube feeding will be retrospectively reviewed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Year
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Krysmaru B AraujoTorres, MD
Role: STUDY_DIRECTOR
Société des Produits Nestlé (SPN)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Chicago, Comer Children's Hospital
Chicago, Illinois, United States
Le Bonheur Children's Hospital
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16.04.US.HCN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.